Unintended Consequences of OHIP Plus

With the OHIP Plus finally kicking in, I wonder if there have been any unintended consequences that we are just starting to realize. Many have argued it is a political move from the Liberal party to secure a “sure win” in the upcoming election. Others may see it as a step toward a Universal Pharmacare in Canada.  One way or another, its intention is to allow all children and youth under the age of 25 in Ontario to have access to prescription medications without any barriers.

Continue reading Unintended Consequences of OHIP Plus

Advertisements

Pharmacological Treatment for Alcohol Use Disorder

The American Psychiatry Association has just released new practice guidelines for the pharmacological treatment of patients with alcohol use disorder. For the full guidelines, click here.  In this guideline, the use of these 5 agents have been discussed: naltrexone, acamprosate, disulfiram, topiramate and gabapentin.

Continue reading Pharmacological Treatment for Alcohol Use Disorder

Drug Shortage – A Request for Further Research

I have ranted about drug shortages in the past. It is extremely frustrating that medications go on drug shortage with little warning, or when drug shortages occur, simple modification of the therapy isn’t an option.

Continue reading Drug Shortage – A Request for Further Research

New Year’s Resolution: Looking Beyond the Script

Happy New Year! As we begin the year of 2018, there are few things that I want to work on professionally.  But the main mission is to focus on delivering values beyond the script.

Continue reading New Year’s Resolution: Looking Beyond the Script

How will Drug coverage change on Jan 1 2018 for Children and Youth?

If you live in Ontario, OHIP Plus will be effective as of Jan 1, 2018 which means the Ontario Drug Benefits Program will pay for a number of prescription medications for anyone below the age of 25. So what do you really need to know?

Continue reading How will Drug coverage change on Jan 1 2018 for Children and Youth?